Katrina J. Church - Mar 14, 2024 Form 4 Insider Report for Bioventus Inc. (BVS)

Role
SVP & Chief Compliance Officer
Signature
/s/ Anthony D'Adamio, Attorney-in-Fact
Stock symbol
BVS
Transactions as of
Mar 14, 2024
Transactions value $
$0
Form type
4
Date filed
3/18/2024, 08:45 PM
Previous filing
Jul 5, 2023
Next filing
Mar 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BVS Class A Common Stock Options Exercise +3.46K +29.22% 15.3K Mar 14, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BVS Restricted Stock Units Options Exercise $0 -3.46K -33.34% $0.00 6.91K Mar 14, 2024 Class A Common Stock 3.46K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2 The original grant of 13,823 RSUs vest in four approximately equal annual installments beginning on March 14, 2023.